FDA环氧乙烷灭菌设施 III 类设备变更的过渡性执法政策_中英文版
VIP专享
Contains Nonbinding Recommendations
Transitional Enforcement Policy for
Ethylene Oxide Sterilization Facility
Changes for Class III Devices
Guidance for Industry and
Food and Drug Administration Staff
Document issued on November 26, 2024.
For questions about this document regarding CDRH-regulated devices, contact CDRH-ETO-
SiteChange@fda.hhs.gov.
For questions about this document regarding CBER-regulated devices, contact
ocod@fda.hhs.gov.
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Devices and Radiological Health
Center for Biologics Evaluation and Research
Contains Nonbinding Recommendations
Preface
Public Comment
You may submit electronic comments and suggestions at any time for Agency consideration to
https://www.regulations.gov. Submit written comments to the Dockets Management Staff, Food
and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852-
1740. Identify all comments with the docket number FDA-2024-D-2274. Comments may not be
acted upon by the Agency until the document is next revised or updated.
Additional Copies
CDRH
Additional copies are available from the Internet. You may also send an email request to CDRH-
Guidance@fda.hhs.gov to receive a copy of the guidance. Please include the document number
GUI00007027 and complete title of the guidance in the request.
CBER
Additional copies of this guidance are available from the Office of Communication, Outreach
and Development (OCOD), 10903 New Hampshire Ave., Bldg. 71, Rm. 3128, Silver Spring,
MD 20993-0002, or by calling 1-800-835-4709 or 240-402-8010, or email ocod@fda.hhs.gov, or
from the Internet at https://www.fda.gov/vaccines-blood-biologics/guidance-compliance-
regulatory-information-biologics.
For questions on the content of this guidance, contact OCOD at the phone numbers or email
address listed above.
摘要:
展开>>
收起<<
ContainsNonbindingRecommendationsTransitionalEnforcementPolicyforEthyleneOxideSterilizationFacilityChangesforClassIIIDevicesGuidanceforIndustryandFoodandDrugAdministrationStaffDocumentissuedonNovember26,2024.ForquestionsaboutthisdocumentregardingCDRH-regulateddevices,contactCDRH-ETO-SiteChange@fda.h...
声明:如果您的权利被侵害,请联系我们的进行举报。
相关推荐
-
IVD产品设计开发以及注册申报流程图VIP免费
2024-04-12 163 -
医疗器械设计开发控制指南VIP免费
2024-04-12 235 -
YY∕T 0664-2020医疗器械软件软件生存周期过程核查表VIP免费
2024-04-12 224 -
创新医疗器械注册申报流程
2024-05-02 121 -
20221028_医疗器械生产现场核查缺陷分析交流(江苏药省监局审核查验中心) (1)VIP免费
2024-05-09 77 -
医疗器械网络安全漏洞自评报告VIP专享
2024-11-18 269 -
内审检查表 MDR法规VIP免费
2025-04-07 192 -
07.产品风险管理报告VIP免费
2025-09-12 18 -
06.可用性确认报告或可用性总结性测试报告VIP免费
2025-09-12 27 -
特定上市前提交审查的质量管理体系信息-2025草案_中英文版VIP专享
2025-11-03 21
作者:薛定谔的龙猫
分类:专业资料
价格:80质量币
属性:42 页
大小:1.13MB
格式:PDF
时间:2025-11-12

